Document Detail

Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
MedLine Citation:
PMID:  19203646     Owner:  NLM     Status:  MEDLINE    
Listeria monocytogenes is a facultative intracellular gram-positive bacterium that naturally infects professional antigen presenting cells (APC) to target antigens to both class I and class II antigen processing pathways. This infection process results in the stimulation of strong innate and adaptive immune responses, which make it an ideal candidate for a vaccine vector to deliver heterologous antigens. This ability of L. monocytogenes has been exploited by several researchers over the past decade to specifically deliver tumor-associated antigens that are poorly immunogenic such as self-antigens. This review describes the preclinical studies that have elucidated the multiple immune responses elicited by this bacterium that direct its ability to influence tumor growth.
Anu Wallecha; Kyla Driscoll Carroll; Paulo Cesar Maciag; Sandra Rivera; Vafa Shahabi; Yvonne Paterson
Related Documents :
17467766 - Human herpesvirus-6a and -6b encode viral immunoevasins that downregulate class i mhc m...
17616966 - Mgl-mediated internalization and antigen presentation by dendritic cells: a role for ty...
2580936 - Genetic markers of the antigen-specific t cell receptor locus.
2428626 - Antigen-ia interaction and the proteolytic processing of antigen: the structure of the ...
3749816 - Retention of immune complexes by murine lymph node or spleen follicular dendritic cells...
11992156 - Additives and protein-dna combinations modulate the humoral immune response elicited by...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advances in applied microbiology     Volume:  66     ISSN:  0065-2164     ISO Abbreviation:  Adv. Appl. Microbiol.     Publication Date:  2009  
Date Detail:
Created Date:  2009-02-10     Completed Date:  2009-03-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370413     Medline TA:  Adv Appl Microbiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1-27     Citation Subset:  IM    
Department of Antibody Technology ImClone Systems, a wholly-owned subsidiary of Eli Lilly & Co. New York, NY 10014, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigen-Presenting Cells / immunology
Cancer Vaccines / immunology,  therapeutic use*
Listeria Infections / immunology*,  microbiology
Listeria monocytogenes / genetics,  immunology*,  pathogenicity
Neoplasms / immunology,  therapy*
T-Lymphocytes, Regulatory / immunology
Vaccines, Synthetic / immunology,  therapeutic use*
Virulence Factors / genetics,  immunology
Reg. No./Substance:
0/Cancer Vaccines; 0/Vaccines, Synthetic; 0/Virulence Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prophylaxis of travel-related thrombosis in women.
Next Document:  Diagnosis of clinically relevant fungi in medicine and veterinary sciences.